NYSE:RVTY Revvity (RVTY) Stock Price, News & Analysis $160.43 +1.66 (+1.04%) Closing price 10/26/2026 03:59 PM EasternExtended Trading$163.16 +2.73 (+1.70%) As of 06:41 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Revvity Stock (NYSE:RVTY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Revvity alerts:Sign Up Key Stats Today's Range$159.10▼$161.6750-Day Range$113.99▼$158.8252-Week Range$81.22▼$166.25Volume1.09 million shsAverage Volume1.81 million shsMarket Capitalization$17.90 billionP/E Ratio76.39Dividend Yield0.17%Price Target$124.43Consensus RatingHold Company Overview Revvity, Inc. provides technology, products and services for the life sciences and diagnostics markets. The company supports pharmaceutical and biotechnology research, clinical laboratories and other healthcare organizations with tools used in drug discovery, biological research, disease detection and laboratory testing. Its offerings include laboratory instruments, reagents, consumables, software and workflow solutions. Key areas include genomics, proteomics, cellular analysis, imaging, screening, automation and reproductive health, as well as newborn screening and other diagnostic applications. Revvity also provides services and solutions designed to help customers manage research and testing workflows. Revvity became an independent public company in 2023 following the separation of PerkinElmer’s Applied, Food and Enterprise Services businesses from its life sciences and diagnostics operations. The company serves customers internationally and is led by President and Chief Executive Officer Prahlad Singh.AI Generated. May Contain Errors. Read More Revvity Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks48th Percentile Overall ScoreRVTY MarketRank™: 2.39727802981 of 5 starsRevvity scored higher than 48% of companies evaluated by MarketBeat, and ranked 507th out of 907 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingHold Consensus RatingRevvity has received a consensus rating of Hold. The company's average rating score is 2.28, and is based on no strong buy ratings, 5 buy ratings, 13 hold ratings, and no sell ratings.Downside RiskRevvity has a consensus price target of $124.43, representing about 22.4% downside from its current price of $160.43.Amount of Analyst CoverageRevvity has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Revvity's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth10.45% Earnings GrowthEarnings for Revvity are expected to grow by 10.45% in the coming year, from $5.36 to $5.92 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Revvity is 76.39, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.19.Price to Earnings Ratio vs. SectorThe P/E ratio of Revvity is 76.39, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 35.91.Price to Earnings Growth RatioRevvity has a PEG Ratio of 2.89. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioRevvity has a P/B Ratio of 2.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Revvity's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.78% of the float of Revvity has been sold short.Short Interest Ratio / Days to CoverRevvity has a short interest ratio ("days to cover") of 3.56, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Revvity has recently increased by 1.42%, indicating that investor sentiment is decreasing. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldRevvity has a dividend yield of 0.18%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthRevvity does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Revvity is 13.33%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Revvity will have a dividend payout ratio of 4.73% next year. This indicates that Revvity will be able to sustain or increase its dividend.Read more about Revvity's dividend. News and Social Media3.2 / 5News Sentiment0.16 News SentimentRevvity has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Revvity this week, compared to 5 articles on an average week.Search Interest12 people have searched for RVTY on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.MarketBeat Follows4 people have added Revvity to their MarketBeat watchlist in the last 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Revvity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,281,439.00 in company stock.Percentage Held by Insiders0.85% of the stock of Revvity is held by insiders.Percentage Held by Institutions86.65% of the stock of Revvity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Revvity's insider trading history. Receive RVTY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Revvity and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RVTY Stock News HeadlinesRevvity Inc. (NYSE:RVTY) Stock Rated "Hold" by Sell-Side Brokerages4 hours ago | americanbankingnews.comRevvity (RVTY) Projected to Announce Earnings on TuesdayOctober 27 at 1:30 AM | americanbankingnews.comLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, protect it. This report normally sells for 29.97, but it's available as a free download for a limited time.October 27 at 1:00 AM | Profits Run (Ad)Revvity: High PEG Ratio Leaves Limited Near-Term UpsideOctober 22, 2026 | seekingalpha.comRevvity: A Diagnostics Annuity Is Quietly Funding An AI Data EngineOctober 22, 2026 | seekingalpha.comRevvity (RVTY) Gets a Hold from BernsteinOctober 20, 2026 | theglobeandmail.comJ.P. Morgan Sticks to Their Hold Rating for Revvity (RVTY)October 19, 2026 | theglobeandmail.comRevvity (NYSE:RVTY) CAO Sells $13,060.32 in StockOctober 3, 2026 | insidertrades.comSee More Headlines RVTY Stock Analysis - Frequently Asked Questions How have RVTY shares performed this year? Revvity's stock was trading at $96.81 at the start of the year. Since then, RVTY shares have increased by 65.7% and is now trading at $160.4270. How were Revvity's earnings last quarter? Revvity Inc. (NYSE:RVTY) released its quarterly earnings results on Tuesday, August, 4th. The company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.20. The business's revenue for the quarter was down 1.3% on a year-over-year basis. Read the conference call transcript. Is Revvity doing a stock buyback? Revvity's board initiated a stock repurchase plan on Monday, October 27th 2025, which permits the company to buy back $1 billion in outstanding shares, according to EventVestor. This means that the company could reacquire up to 8.7% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's leadership believes its stock is undervalued. Who are Revvity's major shareholders? Revvity's top institutional investors include Nisa Investment Advisors LLC (0.07%), Sterling Capital Management LLC (0.01%), Yousif Capital Management LLC (0.01%) and Inspire Investing LLC (0.01%). Insiders that own company stock include Prahlad R Singh, Joel S Goldberg, Maxwell Krakowiak, Anita Gonzales and Tajinder S Vohra. View institutional ownership trends. How do I buy shares of Revvity? Shares of RVTY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Revvity own? Based on aggregate information from My MarketBeat watchlists, some other companies that Revvity investors own include NVIDIA (NVDA), Trade Desk (TTD), Merck & Co., Inc. (MRK), Thermo Fisher Scientific (TMO), Taiwan Semiconductor Manufacturing (TSM), Uber Technologies (UBER) and Veeva Systems (VEEV). Company Calendar Record date for 8/7 Dividend7/17/2026Ex-Dividend for 8/7 Dividend7/17/2026Last Earnings8/04/2026Dividend Payable8/07/2026Record date for 11/13 Dividend10/23/2026Ex-Dividend for 11/13 Dividend10/23/2026Today10/27/2026Next Earnings (Confirmed)11/03/2026Dividend Payable11/13/2026Investor Day 202611/13/2026Jefferies Global Healthcare Conference11/17/20269th Annual Evercore ISI HealthCONx Conference12/02/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 RVTY's financial health is in the Green zone, according to TradeSmith. RVTY has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNYSE:RVTY CIK31791 Webwww.revvity.com Phone(781) 663-6900Fax781-663-5985Employees11,000Year Founded1937Price Target and Rating Average Price Target for Revvity$124.43 High Price Target$175.00 Low Price Target$90.00 Potential Upside/Downside-22.4%Consensus RatingHold Rating Score (0-4)2.28 Research Coverage18 Analysts Profitability EPS (Trailing Twelve Months)$2.10 Trailing P/E Ratio76.39 Forward P/E Ratio29.93 P/E Growth2.89Net Income$241.20 million Net Margins8.16% Pretax Margin8.96% Return on Equity8.34% Return on Assets5.01% Debt Debt-to-Equity Ratio0.36 Current Ratio1.80 Quick Ratio1.50 Sales & Book Value Annual Sales$2.86 billion Price / Sales6.27 Cash Flow$8.91 per share Price / Cash Flow18.01 Book Value$63.95 per share Price / Book2.51Miscellaneous Outstanding Shares111,590,000Free Float110,638,000Market Cap$17.90 billion OptionableOptionable Beta1.06 Social Links 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (NYSE:RVTY) was last updated on 10/26/2026 by MarketBeat.com Staff. From Our Partners80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredTwo charts tell you the future…Gold miners are posting record cash flows, outperforming every other sector, yet mining still makes up just 1%...Golden Portfolio | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revvity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revvity With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
